IDEXX Laboratories (IDXX) Stock Forecast & Price Target
Score
IDEXX Laboratories, Inc. price target
| IDXX | |
|---|---|
| Low | $700.00 |
| Average | $716.67 |
| High | $740.00 |
| Upside vs current price | +1.8% |
The average target of $716.67 is +1.8% versus the current IDXX price of $704.23.
IDEXX Laboratories, Inc. analyst ratings
| Rating | Analysts |
|---|---|
| Strong buy | 4 |
| Buy | 5 |
| Hold | 4 |
| Sell | 1 |
| Strong sell | 1 |
| Consensus | Buy |
15 analysts cover IDXX.
IDEXX Laboratories, Inc. EPS and revenue estimates
Published annual figures for IDXX on this page are 2026 EPS $14.91, 2027 EPS $16.84. Coverage under three analysts is omitted.
| Fiscal year | EPS estimate | Revenue estimate |
|---|---|---|
| 2026 | $14.91 | $4.75B |
| 2027 | $16.84 | $5.16B |
Is IDEXX Laboratories, Inc. a buy or sell?
Of the 15 analysts covering IDEXX Laboratories, Inc., 9 rate it a buy (4 strong buy and 5 buy), 4 rate it a hold, and 2 rate it a sell (1 sell and 1 strong sell).
The IDXX consensus label is Buy, beside 9 buy-side ratings and 2 sell-side ratings.
The average target of $716.67 implies +1.8% versus the current price of $704.23.
The IDXX rating block is 15 published views with a Buy label. It does not tell you whether to buy or sell.
Reading the IDEXX Laboratories, Inc. forecast
the IDEXX Laboratories, Inc. has a tight target cluster: $700.00 to $740.00, average $716.67.
The gap from the $704.23 price to the IDXX average is +1.8%.
the IDEXX Laboratories, Inc. does not have a single rating camp: 9 of 15 analysts are on the buy side, 4 are at hold, and 2 are on the sell side, and the published consensus is Buy.
IDXX targets have not moved much: $689.00 recently, $689.00 across the quarter.
the IDEXX Laboratories, Inc. is followed by 15 analysts, so the range matters more than any one target.
IDEXX Laboratories, Inc. forecast questions
What is the IDXX price target?
The published range for IDXX is $700.00 to $740.00, with an average of $716.67. That average is +1.8% versus the current price of $704.23.
Is IDEXX Laboratories, Inc. a buy or sell?
Of the 15 analysts covering IDEXX Laboratories, Inc., 9 rate it a buy, 4 rate it a hold, and 2 rate it a sell. The consensus is Buy, leaving IDXX at 9 buy ratings, 4 holds, and 2 sells.
What is the EPS estimate for IDEXX Laboratories, Inc.?
Analyst EPS estimates for IDEXX Laboratories, Inc.: 2026 $14.91, 2027 $16.84.
What is the revenue estimate for IDEXX Laboratories, Inc.?
Analyst revenue estimates for IDEXX Laboratories, Inc.: 2026 $4.75B, 2027 $5.16B.
How many analysts cover IDXX?
15 analysts cover IDXX. Their consensus on IDXX is Buy, across those 15.